PP PARKWAY SPECIALTY PHARMACY
LIVE

Serial Number

88156918

Owner

Parkway Pharmacy LP

Attorney

Robert Fellman

First Use Date

Aug 10, 2018

Filing Date

Oct 16, 2018

Add to watchlist:

No watchlists yet
View on USPTO

PP PARKWAY SPECIALTY PHARMACY Trademark

Serial Number: 88156918 • Registration: 5909996

PP PARKWAY SPECIALTY PHARMACY is a trademark filed by Parkway Pharmacy LP on October 16, 2018. The trademark is classified under Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Parkway Pharmacy LP

3502 US Highway 9
Howell Township, NJ 077313345

Entity Type: 13

Trademark Details

Filing Date

October 16, 2018

Registration Date

November 12, 2019

First Use Anywhere

August 10, 2018

First Use in Commerce

August 10, 2018

Published for Opposition

July 9, 2019

Goods & Services

Business administration of pharmacy reimbursement programs and services; institutional retail pharmacy services; mail order pharmacy services; mail services, namely, receiving and processing international and domestic mail for infusion into established postal services; pharmaceutical cost management services and drug utilization review services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; retail pharmacy services; specialized retail pharmacy services for patients with particular medical conditions

Healthcare; nursing care; nursing services; pharmaceutical advice; pharmacists' services to make up prescriptions; dispensing of pharmaceuticals; health care services, namely, disease management programs; home nursing aid services; home-visit nursing care; mobile healthcare services; preparation of prescriptions by pharmacists; providing healthcare information; providing educational information about healthcare; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing personalized healthcare and medical information in the nature of individualized patient counseling for rare, orphan, ultra-orphan and complex disease

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jan 14, 2026 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jan 14, 2026 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 13, 2026 APRE
TEAS SECTION 8 RECEIVED
Sep 4, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 12, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 10, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 9, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 22, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 22, 2019 AITU
USE AMENDMENT FILED
Sep 3, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 3, 2019 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 3, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2019 NONP
ASSIGNED TO LIE
Jun 4, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
May 22, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 22, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
May 22, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 22, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 16, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 16, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 16, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 25, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 30, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 30, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 30, 2019 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2018 NWOS
NEW APPLICATION ENTERED
Oct 19, 2018 NWAP